Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Psychopharmacology (Berl). 2016 Aug 24;233(21-22):3803–3813. doi: 10.1007/s00213-016-4415-6

Figure 3.

Figure 3

Scatterplot of the relationship between changes in negative symptom severity and changes antipsychotic-related dopamine D2/3 receptor occupancy in various striatal regions following antipsychotic dose reduction.